Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

Effect of ridogrel, a combined thromboxane A2 synthase inhibitor/ prostaglandin endoperoxide receptor antagonist, on the lysis of platelet-rich coronary arterial thrombi with recombinant tissue-type plasminogen activator in a canine model

Fibrinolysis and Proteolysis ◽

10.1016/0268-9499(92)90042-g ◽

1992 ◽

Vol 6 (1) ◽

pp. 7-15 ◽

Cited By ~ 5

Author(s):

D. Collen ◽

M. Masuda ◽

H.Rong Lu ◽

W. Flameng ◽

A. Verheyen ◽

...

Keyword(s):

Receptor Antagonist ◽

Plasminogen Activator ◽

Thromboxane A2 ◽

Canine Model ◽

Tissue Type ◽

Prostaglandin Endoperoxide ◽

Type Plasminogen Activator ◽

Synthase Inhibitor

Prevention of Reocclusion following Tissue Type Plasminogen Activator-Induced Thrombolysis by the RGD-Containing Peptide, Echistatin, in a Canine Model of Coronary Thrombosis

Pharmacology ◽

10.1159/000138817 ◽

1991 ◽

Vol 42 (6) ◽

pp. 340-348 ◽

Cited By ~ 17

Author(s):

Marie A. Holahan ◽

Michael J. Mellott ◽

Victor M. Garsky ◽

Ronald J. Shebuski

Keyword(s):

Plasminogen Activator ◽

Coronary Thrombosis ◽

Canine Model ◽

Tissue Type ◽

Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis.

Circulation ◽

10.1161/01.cir.82.1.169 ◽

1990 ◽

Vol 82 (1) ◽

pp. 169-177 ◽

Cited By ~ 44

Author(s):

R J Shebuski ◽

I J Stabilito ◽

G R Sitko ◽

M H Polokoff

Keyword(s):

Plasminogen Activator ◽

Coronary Thrombosis ◽

Canine Model ◽

Tissue Type ◽

Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.

Circulation ◽

10.1161/01.cir.77.3.678 ◽

1988 ◽

Vol 77 (3) ◽

pp. 678-684 ◽

Cited By ~ 102

Author(s):

P Golino ◽

J H Ashton ◽

P Glas-Greenwalt ◽

J McNatt ◽

L M Buja ◽

...

Keyword(s):

Plasminogen Activator ◽

Coronary Thrombosis ◽

Thromboxane A2 ◽

Tissue Type ◽

Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.

Circulation ◽

10.1161/01.cir.81.2.617 ◽

1990 ◽

Vol 81 (2) ◽

pp. 617-627 ◽

Cited By ~ 57

Author(s):

J K Mickelson ◽

P J Simpson ◽

M Cronin ◽

J W Homeister ◽

E Laywell ◽

...

Keyword(s):

Coronary Artery ◽

Plasminogen Activator ◽

Canine Model ◽

Tissue Type ◽

Antiplatelet Antibody ◽

Effect of ridogrel on the lysis of platelet-rich coronary artery thrombi with recombinant tissue-type plasminogen activator in a canine model

Journal of Molecular and Cellular Cardiology ◽

10.1016/0022-2828(90)91729-q ◽

1990 ◽

Vol 22 ◽

pp. S68

Author(s):

H.R. Lu ◽

M. Masuda ◽

F. De Clerk ◽

W. Flameng ◽

D. Collen

Keyword(s):

Coronary Artery ◽

Plasminogen Activator ◽

Canine Model ◽

Tissue Type ◽

The Thrombolytic Effects of Native Tissue-Type Plasminogen Activator (AK-124) on Experimental Canine Coronary Thrombosis

Angiology ◽

10.1177/000331978904000502 ◽

1989 ◽

Vol 40 (5) ◽

pp. 429-435 ◽

Cited By ~ 1

Author(s):

Takanobu Tomaru ◽

Yasumi Uchida ◽

Hiroyuki Sonoki ◽

Masami Tsukamoto ◽

Tsuneaki Sugimoto

Keyword(s):

Plasminogen Activator ◽

Coronary Thrombosis ◽

Tissue Type ◽

Native Tissue ◽

Type Plasminogen Activator ◽

Experimental Canine

Comparative Study of a Mutant Tissue-type Plasminogen Activator, YM866, with a Tissue-type Plasminogen Activator in a Canine Model of Femoral Arterial Thrombosis

Journal of Pharmacy and Pharmacology ◽

10.1111/j.2042-7158.1996.tb05897.x ◽

1996 ◽

Vol 48 (10) ◽

pp. 1041-1048 ◽

Cited By ~ 1

Author(s):

T. Kawasaki ◽

S. Kaku ◽

Y. Sakai ◽

T. Takenaka

Keyword(s):

Comparative Study ◽

Plasminogen Activator ◽

Arterial Thrombosis ◽

Canine Model ◽

Tissue Type ◽

Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.

Circulation ◽

10.1161/01.cir.72.6.1346 ◽

1985 ◽

Vol 72 (6) ◽

pp. 1346-1354 ◽

Cited By ~ 61

Author(s):

K A Fox ◽

A K Robison ◽

R M Knabb ◽

T L Rosamond ◽

B E Sobel ◽

...

Keyword(s):

Plasminogen Activator ◽

Coronary Thrombosis ◽

Tissue Type ◽

Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis

The American Journal of Cardiology ◽

10.1016/0002-9149(86)90336-x ◽

1986 ◽

Vol 58 (9) ◽

pp. 673-679 ◽

Cited By ~ 61

Author(s):

Harry D. Garabedian ◽

Herman K. Gold ◽

Robert C. Leinbach ◽

Tsunehiro Yasuda ◽

Jennifer A. Johns ◽

...

Keyword(s):

Plasminogen Activator ◽

Human Tissue ◽

Coronary Thrombosis ◽

Tissue Type ◽

Type Plasminogen Activator ◽

Hemostatic Effects ◽

Dose Dependent